Back to Trades
Ceesay Abraham
DirectorCIK 0001722140
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 25
- Companies
- 3
- Active
- 2025–2026
Ceesay Abraham, Director, has filed 8 reports across 3 companies, totaling $3.8M in disclosed volume. Sales ($3.6M) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| May 11 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Ceesay Abraham | Director | Grant | $255.4K |
| Feb 19 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $320.4K |
| Jan 22 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $285.1K |
| Dec 18 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $323.5K |
| Nov 18 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $275.0K |
| Oct 16 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $281.7K |
| Sep 19 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $2.0M |
| Sep 8 | PCRX Pacira BioSciences, Inc. | Ceesay Abraham | Director | Sell | $64.0K |
8 filings